Fundamental dimension Equity attribute | FMHSPeer $0.1450.00% Cap $2.77MP/E -0.8x QuantScore38/100 | CRTDPeer $4.85▲+0.12% Cap $2.87MP/E -0.4x QuantScore28/100 | HDUPLeader $0.0070.00% Cap $1.66MP/E -11.7x QuantScore43/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
59/100 |
41/100 |
63/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 0/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 23/100 | 31/100 | 10/100 |
Growth Revenue / earnings growth & margins | 36/100 | 40/100 | 65/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.8x | -0.4x | -11.7x |
Forward P/E (next FY) | — | -0.0x | — |
EV / EBITDA (TTM) | -107.1x | -0.2x | -19.6x |
Price / Sales | 4446.8x | 1.1x | 106.2x |
Price / Free Cash Flow | -11.1x | -0.5x | -21.3x |
PEG ratio | 0.00 | -0.00 | 0.08 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 4 / 9 | 4 / 9 |
Altman Z-Score | -12.75 (Distress) | -46.04 (Distress) | -2.11 (Distress) |
Total debt / equity | -0.18 | -6.79 | 1.73 |
Quick ratio | 0.2x | 1.2x | 0.1x |
Interest coverage | -0.5x | -9.8x | -14.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -85.0% | +110.1% | +63.1% |
Net income growth YoY | +15.3% | -4.1% | +26.9% |
Gross margin (TTM) | 79.9% | 66.3% | 100.0% |
Operating margin (FY) | -65881.5% | -411.0% | -998.3% |
FCF margin (FY) | -28735.5% | -103.8% | -498.8% |
5. Trailing price performancePrice change over period |
1M return | 0.0% | +23.4% | -40.2% |
3M return | -25.6% | -4.9% | -20.9% |
6M return | +17.0% | -50.3% | +100.0% |
Year to date | +40.8% | -57.5% | +75.0% |
1Y return | -3.3% | +10.2% | +15.5% |
3Y return | +280.6% | -97.8% | -47.2% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.0359 -124.8% premium | $-12.99 -367.9% premium | $-0.0023 -132.8% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |